Sch 1000: a New Anticholinergic Bronchodilator
Overview
Authors
Affiliations
Sch 1000 is a derivative of atropine with equivalent bronchodilator activity. A double blind controlled study of Sch 1000 administered to asthmatic subjects by inhalation in 4 doses from 10 mug to 80 mug was conducted. The onset of action was between 15 and 30 min, compared to 5 min for isoproterenol, but persisted for 4 hours compared to 1 hour for isoproterenol. The maximal level of bronchodilatation produced by Sch 1000 was comparable to but not as great as that after isoproterenol. Dose-response data suggested that maximal bronchodilatation may be achieved by 10 to 20 mug of Sch 1000; larger doses did not result in significantly greater increases in forced expiratory volume in 1 sec or maximal mid-expiratory flow. The Sch 1000-mediated increase in maximal mid-expiratory flow was significantly greater than that of forced expiratory volume in 1 sec. Fewer side effects were encountered after Sch 1000 than after isoproterenol and no atropine-like effects could be attributed to Sch 1000 in the doses studied.
Anticholinergic agents for chronic asthma in adults.
Westby M, Benson M, Gibson P Cochrane Database Syst Rev. 2004; (3):CD003269.
PMID: 15266477 PMC: 6483359. DOI: 10.1002/14651858.CD003269.pub2.
Anticholinergic therapy for chronic asthma in children over two years of age.
McDonald N, Bara A Cochrane Database Syst Rev. 2003; (3):CD003535.
PMID: 12917970 PMC: 8717339. DOI: 10.1002/14651858.CD003535.
Ipratropium bromide in children with asthma.
Mann N, HILLER E Thorax. 1982; 37(1):72-4.
PMID: 6461943 PMC: 459250. DOI: 10.1136/thx.37.1.72.
Synergism between ipratropium and theophylline in asthma.
Kreisman H, Frank H, Wolkove N, Gent M Thorax. 1981; 36(5):387-91.
PMID: 6458919 PMC: 471515. DOI: 10.1136/thx.36.5.387.
Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis.
Kattan M, Mansell A, Levison H, Corey M, Krastins I Thorax. 1980; 35(7):531-5.
PMID: 6449095 PMC: 471328. DOI: 10.1136/thx.35.7.531.